CN102274467B - 一种乳核散结胶囊的检测方法 - Google Patents
一种乳核散结胶囊的检测方法 Download PDFInfo
- Publication number
- CN102274467B CN102274467B CN 201110238342 CN201110238342A CN102274467B CN 102274467 B CN102274467 B CN 102274467B CN 201110238342 CN201110238342 CN 201110238342 CN 201110238342 A CN201110238342 A CN 201110238342A CN 102274467 B CN102274467 B CN 102274467B
- Authority
- CN
- China
- Prior art keywords
- solution
- methyl alcohol
- water
- adds
- filtrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 9
- 210000000481 breast Anatomy 0.000 title abstract description 25
- 238000001514 detection method Methods 0.000 claims abstract description 37
- 241000736246 Pyrola Species 0.000 claims abstract description 21
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 claims abstract description 14
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 claims abstract description 14
- QMNWISYXSJWHRY-BCBPIKMJSA-N astragaloside IV Natural products CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O QMNWISYXSJWHRY-BCBPIKMJSA-N 0.000 claims abstract description 14
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 claims abstract description 14
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 claims abstract description 14
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 claims abstract description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 276
- 239000000243 solution Substances 0.000 claims description 168
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 144
- 238000012360 testing method Methods 0.000 claims description 78
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 76
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 73
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 69
- 239000013558 reference substance Substances 0.000 claims description 60
- 239000000284 extract Substances 0.000 claims description 57
- 239000000706 filtrate Substances 0.000 claims description 57
- 239000000463 material Substances 0.000 claims description 56
- 239000003921 oil Substances 0.000 claims description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- 238000002360 preparation method Methods 0.000 claims description 41
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 40
- 239000003795 chemical substances by application Substances 0.000 claims description 36
- 239000007788 liquid Substances 0.000 claims description 33
- 239000012046 mixed solvent Substances 0.000 claims description 33
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 30
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 26
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 26
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 26
- 239000000741 silica gel Substances 0.000 claims description 26
- 229910002027 silica gel Inorganic materials 0.000 claims description 26
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- 239000003814 drug Substances 0.000 claims description 24
- 238000012545 processing Methods 0.000 claims description 23
- 238000010992 reflux Methods 0.000 claims description 22
- 239000007921 spray Substances 0.000 claims description 21
- 238000010438 heat treatment Methods 0.000 claims description 17
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 16
- 239000000047 product Substances 0.000 claims description 16
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 14
- 239000007767 bonding agent Substances 0.000 claims description 14
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 14
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 14
- 238000004587 chromatography analysis Methods 0.000 claims description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 13
- 239000006210 lotion Substances 0.000 claims description 13
- 238000005406 washing Methods 0.000 claims description 13
- 229920006395 saturated elastomer Polymers 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 201000010099 disease Diseases 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 9
- 239000000341 volatile oil Substances 0.000 claims description 9
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 8
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 8
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 8
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 8
- 238000010790 dilution Methods 0.000 claims description 8
- 239000012895 dilution Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 235000019253 formic acid Nutrition 0.000 claims description 8
- 210000005075 mammary gland Anatomy 0.000 claims description 8
- 239000000377 silicon dioxide Substances 0.000 claims description 7
- FZRCKLPSHGTOAU-UHFFFAOYSA-N 6-amino-1,4-dimethylcyclohexa-2,4-diene-1-carbaldehyde Chemical compound CC1=CC(N)C(C)(C=O)C=C1 FZRCKLPSHGTOAU-UHFFFAOYSA-N 0.000 claims description 6
- 241000545442 Radix Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 235000018905 epimedium Nutrition 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 241000208421 Ericaceae Species 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 241000512259 Ascophyllum nodosum Species 0.000 claims 2
- 244000163122 Curcuma domestica Species 0.000 claims 2
- 235000003392 Curcuma domestica Nutrition 0.000 claims 2
- 241001074093 Echinopsis Species 0.000 claims 2
- 241000424773 Epimedium alpinum Species 0.000 claims 2
- 240000002045 Guettarda speciosa Species 0.000 claims 2
- 241000722921 Tulipa gesneriana Species 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 235000003373 curcuma longa Nutrition 0.000 claims 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Natural products O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 2
- 235000013976 turmeric Nutrition 0.000 claims 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 claims 1
- 238000004809 thin layer chromatography Methods 0.000 abstract description 5
- 241000213006 Angelica dahurica Species 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 208000030270 breast disease Diseases 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 241000125175 Angelica Species 0.000 description 6
- 206010020718 hyperplasia Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 206010006298 Breast pain Diseases 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001016310 Epimedium grandiflorum Species 0.000 description 2
- 206010016613 Fibroadenoma of breast Diseases 0.000 description 2
- 208000006662 Mastodynia Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000003149 breast fibroadenoma Diseases 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000003163 gonadal steroid hormone Substances 0.000 description 2
- 201000000079 gynecomastia Diseases 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030247 Oestrogen deficiency Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000003667 hormone antagonist Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
序号 | 仪器名称 | 规格 | 产地 | 用途 |
1 | 紫外光灯 | 365nm | 北京光学仪器厂 | 检测当归挥发油荧光斑点 |
2 | 离心机 | 3500转/分 | 上海精密仪器厂 | 分离溶液 |
3 | 水浴恒温锅 | 四孔 | 北京光学仪器厂 | 蒸发用 |
4 | 电热套 | 500 | 山西鄄城仪器厂 | 加热回流 |
5 | 超声波 | 上海精密仪器厂 | 超声提取 | |
6 | 电热恒温箱 | 北京科伟仪器厂 | 烘干 | |
7 | 高效液相色谱仪 | 单泵 | 日本岛津 | 检测药物、药材含量 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110238342 CN102274467B (zh) | 2011-08-18 | 2011-08-18 | 一种乳核散结胶囊的检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110238342 CN102274467B (zh) | 2011-08-18 | 2011-08-18 | 一种乳核散结胶囊的检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102274467A CN102274467A (zh) | 2011-12-14 |
CN102274467B true CN102274467B (zh) | 2013-09-11 |
Family
ID=45100409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110238342 Active CN102274467B (zh) | 2011-08-18 | 2011-08-18 | 一种乳核散结胶囊的检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102274467B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102716423A (zh) * | 2012-06-21 | 2012-10-10 | 刘坤 | 乳核散结胶囊及其制备方法 |
CN108704018A (zh) * | 2018-07-12 | 2018-10-26 | 南京法尔斯特医药科技有限公司 | 治疗乳腺纤维瘤的中药组合物及其制备与使用方法 |
CN110031588B (zh) * | 2019-03-26 | 2021-02-09 | 浙江金大康动物保健品有限公司 | 一种畜禽抗病毒颗粒的一板多药味快速薄层鉴别方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1588052A (zh) * | 2004-08-27 | 2005-03-02 | 广州中一药业有限公司 | 乳核散结片的质量控制方法 |
-
2011
- 2011-08-18 CN CN 201110238342 patent/CN102274467B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1588052A (zh) * | 2004-08-27 | 2005-03-02 | 广州中一药业有限公司 | 乳核散结片的质量控制方法 |
Non-Patent Citations (3)
Title |
---|
HPLC法测定乳核散结片中淫羊藿苷的含量;林巧玲等;《中药材》;20020331;第25卷(第3期);第197-198页 * |
中华人民共和国卫生部药典委员会.乳核散结片.《卫生部药品标准中药成方制剂(第十八册)》》.1998, * |
林巧玲等.HPLC法测定乳核散结片中淫羊藿苷的含量.《中药材》.2002,第25卷(第3期),第197-198页. |
Also Published As
Publication number | Publication date |
---|---|
CN102274467A (zh) | 2011-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1768854B (zh) | 一种用于溃疡性结肠炎的中药胶囊制剂 | |
CN105687994B (zh) | 一种治疗慢性肾功能衰竭的中药组合物及其制备方法 | |
CN100998821A (zh) | 一种防治消化功能减弱的中药组合物及其制备方法和质量控制方法 | |
CN104138420B (zh) | 一种肉苁蓉药材的加工方法 | |
CN102861123B (zh) | 一种具有促血管新生作用的中药提取物及其制备方法和应用 | |
CN102119992B (zh) | 一种鲜品益母草和鲜品芦荟的药用制剂及其制备方法 | |
CN102091168A (zh) | 一种中药制剂血府逐瘀胶囊的质量控制方法 | |
CN102274467B (zh) | 一种乳核散结胶囊的检测方法 | |
CN102048984A (zh) | 一种益血生片及其制备方法 | |
CN102327434B (zh) | 一种肾康宁胶囊的制备方法 | |
CN101011566B (zh) | 一种治疗慢性盆腔炎的药物组合物及制备方法和质量控制方法 | |
CN101040999B (zh) | 一种治疗打鼾的药物组合物及制备方法和检测方法 | |
CN104840866A (zh) | 一种健脾产品及其检测方法 | |
CN1969958A (zh) | 一种治疗病毒性肝炎的口服制剂的质量控制方法 | |
CN103033585A (zh) | 一种用于治疗乳腺炎、乳腺增生的药物的检测方法 | |
CN105548454A (zh) | 小儿化食中药制剂的质量检测方法 | |
CN102590436B (zh) | 一种藿香正气口服液中甘草的鉴别方法 | |
CN102274332B (zh) | 治疗消化性溃疡的中药散剂的制备工艺 | |
CN101721625B (zh) | 肾炎康复片的鉴别方法 | |
CN105193824B (zh) | 一种灵芝三萜酸活性部位及其制备方法和应用 | |
CN101391070A (zh) | 一种具有抗癌作用的中药组合物的质量控制方法 | |
CN1887328A (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN101288753B (zh) | 一种治疗血尿的中药组合物及其制备方法和检测方法 | |
CN103316074A (zh) | 一种花锚提取物、黄芪提取物与甘草提取物的组合药物及其制剂、应用 | |
CN101274053B (zh) | 腰息痛胶囊的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for detecting capsules for treating nodule in breast by dissolving stasis Effective date of registration: 20160310 Granted publication date: 20130911 Pledgee: Bank of Changan Limited by Share Ltd Xi'an Lianhu District Branch Pledgor: Liu Kun Registration number: 2016990000196 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170329 Granted publication date: 20130911 Pledgee: Bank of Changan Limited by Share Ltd Xi'an Lianhu District Branch Pledgor: Liu Kun Registration number: 2016990000196 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for detecting capsules for treating nodule in breast by dissolving stasis Effective date of registration: 20170821 Granted publication date: 20130911 Pledgee: Bank of Changan Limited by Share Ltd Xi'an Lianhu District Branch Pledgor: Shaanxi Hong Ze Ze Pharmaceutical Co., Ltd.|Liu Kun Registration number: 2017610000094 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20180817 Registration number: 2017610000094 Pledgor after: Liu Kun Pledgor after: Shaanxi Wansheng Medicine Co., Ltd. Pledgor before: Liu Kun Pledgor before: Shaanxi Hong Kang Ze Medicine Co., Ltd. |
|
PM01 | Change of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180904 Granted publication date: 20130911 Pledgee: Bank of Changan Limited by Share Ltd Xi'an Lianhu District Branch Pledgor: Liu Kun|Shaanxi Wansheng Medicine Co., Ltd. Registration number: 2017610000094 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for detecting capsules for treating nodule in breast by dissolving stasis Effective date of registration: 20180904 Granted publication date: 20130911 Pledgee: Bank of Changan Limited by Share Ltd Xi'an Lianhu District Branch Pledgor: Liu Kun|Shaanxi Wansheng Medicine Co., Ltd. Registration number: 2018990000776 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20211220 Granted publication date: 20130911 |
|
PP01 | Preservation of patent right |